about
Update on therapy for superficial mycoses: review article part ISpotlight on tavaborole for the treatment of onychomycosistRNAs as antibiotic targetsBoron chemicals in diagnosis and therapeuticsOnychomycosis: Practical Approaches to Minimize Relapse and RecurrenceThe role of topical antifungal therapy for onychomycosis and the emergence of newer agents.Antifungal effects of a 1444-nm neodymium:Yttrium-aluminum-garnet laser on onychomycosis: a pilot study.The use of the Er:YAG 2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis.Laser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomized, double-blind, controlled trial (LASER-1).Efficacy and safety of 1064-nm Nd:YAG laser in treatment of onychomycosis.The association of fractional CO2 laser 10.600nm and photodynamic therapy in the treatment of onychomycosis.Patient considerations in the management of toe onychomycosis - role of efinaconazole.An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis (.).A review of the mechanism of action of lasers and photodynamic therapy for onychomycosis.Clinical laser treatment of toenail onychomycoses.The prevalence of onychomycosis in the global population: a literature study.Novel antifungal agents: a patent review (2011 - present).Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis.Emerging topical onychomycosis therapies - quo vadis?Tavaborole - a treatment for onychomycosis of the toenails.Epidemiology of onychomycosis in Serbia: a laboratory-based survey and risk factor identification.Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.AS2077715: a novel antifungal antibiotic produced by Capnodium sp. 339855.Onychopharmacokinetics of terbinafine hydrochloride penetration from a novel topical formulation into the human nail in vitro.Biofilms and beyond: expanding echinocandin utility.
P2860
Q24608381-A68D5B18-04DF-4876-B4AA-FADB5E80768AQ26774184-73354B7E-9E21-4F2D-A05F-2E825187D78AQ26822430-9B8EC0A8-767B-401A-84C6-FE706F92D244Q27006075-99DD2CFC-62C7-4B7D-B70B-EED79B3081DBQ28073085-2C93ABB5-EF6A-435E-881E-33FF556FE34EQ33931289-D9675004-BF6B-4D57-AE24-0D0322098368Q34343833-D161A895-8767-4BC8-8F22-FC9B0F750723Q35029151-B96AC87D-35DF-4695-8A93-1E39B49C3A03Q35238148-9DC95366-DC9D-4B0B-957B-BC4EA517E80DQ35606406-954923FA-640C-4FA4-997D-8F75D487AF98Q35777000-8B3E201D-A634-4A61-82FE-8C6331CEB04EQ35827685-75670EB5-32BB-4479-90D1-195B3FC3CF71Q35975837-78AA193A-F02E-4A92-97EC-7490DF0BE687Q36203813-B17C1767-6245-4269-90B0-A8BAC621FDF1Q36335309-097B2DFB-B593-4F0B-A40C-92DBDD2178DDQ38166811-BEA04AAB-9EDB-4BE0-B6C7-D4F8BF65485EQ38176048-A2CB871C-BD13-44DD-911A-EA36B4CD0972Q38195345-4A8621F6-8AF6-445E-9E71-A4F5FBAE7D78Q38268701-6A244174-C24F-4B53-BC27-BE5DE159BCEDQ38878252-E1D23214-7976-4A72-9EC2-91E97E6F0E76Q39548613-A542850F-D233-4418-9C1E-16479F64BF6BQ41019142-F4D5BEC3-D1A3-4B1E-9270-DCBEFD880CECQ44151067-215223B0-328D-459C-8D53-69339ED84782Q46019054-1D843A06-0674-4685-A818-9E0351CEE1C0Q47205366-DE4721FF-388C-4C03-8819-26BD6B12DB5F
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
New therapeutic options for onychomycosis.
@ast
New therapeutic options for onychomycosis.
@en
New therapeutic options for onychomycosis.
@nl
type
label
New therapeutic options for onychomycosis.
@ast
New therapeutic options for onychomycosis.
@en
New therapeutic options for onychomycosis.
@nl
prefLabel
New therapeutic options for onychomycosis.
@ast
New therapeutic options for onychomycosis.
@en
New therapeutic options for onychomycosis.
@nl
P2860
P1476
New therapeutic options for onychomycosis.
@en
P2860
P304
P356
10.1517/14656566.2012.681779
P407
P577
2012-04-25T00:00:00Z